Skip to main content
Year archive

Orexo — 2019 filings

All 30 regulatory filings released by Orexo (ORX) in 2019, sourced directly from the official regulator.

30 Filings
2019 Period
2019 filings (30)
Filing Released Lang
Orexo förvärvar de exklusiva kommersiella rättigheterna i USA för vorvida®, en digital behandling för alkoholberoende med vetenskapligt bevisad effekt
Regulatory Filings
2019-11-27 Swedish
Orexo acquires exclusive US rights to commercialize vorvida®, a digital therapy for alcohol use disorder with scientifically proven efficacy
M&A Activity
2019-11-27 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q3 2019
2019-10-24 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q3 2019
2019-10-24 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-08-30 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-08-29 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-08-28 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-08-20 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-08-12 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-08-06 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q2 2019
2019-07-11 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q2 2019
2019-07-11 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2019-06-28 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2019-06-28 English
Emission och återköp av C-aktier
Share Issue/Capital Change
2019-06-12 Swedish
Issue and repurchase of class C shares
Share Issue/Capital Change
2019-06-12 English
Number of shares and votes in Orexo
Share Issue/Capital Change
2019-05-31 English
Antal aktier och röster i Orexo
Share Issue/Capital Change
2019-05-31 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-02 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-02 English
Annual Report 2018
Annual Report FY 2018
2019-03-21 Swedish
Annual Report 2018
Annual Report FY 2018
2019-03-21 English
Kallelse till årsstämma i Orexo
AGM Information
2019-03-05 Swedish
Notice of Annual General Meeting of Orexo
AGM Information
2019-03-05 English
Antal aktier och röster i Orexo
Share Issue/Capital Change
2019-02-28 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2019-02-28 English
Earnings Release 2018
Earnings Release Q4 2018
2019-01-30 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q4 2018
2019-01-30 English
Positive results from human PK study assessing Orexo’s new intranasal naloxone formulations for opioid overdose reversal
Regulatory Filings
2019-01-07 English
Positiva resultat från human PK-studie av Orexos nya intranasala naloxon-formuleringar för upphävande av effekter vid opioidöverdos
Regulatory Filings
2019-01-07 Swedish